The US Food and Drug Administration (FDA) has approved Pfizer and BioNTech’s mRNA COVID-19 vaccine, Comirnaty, for people 16 years or older. The announcement represents not just the first approved ...
The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
Add Yahoo as a preferred source to see more of our stories on Google. COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 ...
The FDA approved 2025-2026 COVID vaccines from Pfizer (Comirnaty), Moderna (Spikevax, mNexspike), and Novavax (Nuvaxovid), the companies announced on Wednesday. But the agency removed one of the ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
LONDON, Aug 1 (Reuters) - Pfizer (PFE.N), opens new tab and its German partner BioNTech (22UAy.DE), opens new tab on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results